Orange County Business Journal

Jerry Sullivan is editor of the Business Journal. He directs the paper's coverage and layout and oversees a team of award-winning reporters. He also oversees the paper's website. He can be reached at sullivan@ocbj.com.

Recent Stories

Callahan v. Busch; Check Pyott’s Sleeve; Full of Philanthropy

The Dec. 18 date that’s been set for a special shareholders meeting on Valeant Pharmaceuticals’ hostile bid for Irvine-based Allergan didn’t add up to much on Wall Street, where neither company saw its shares do much last week.

Ups & Downs for Allergan; Devil of a Case; Augie on Ice

Last week had some wags wondering if Allergan CEO David Pyott might be forced into an error by spending too much on an acquisition in hopes of putting the Irvine-based drug maker out of reach of hostile pursuers Valeant Pharmaceuticals and New York hedge funder Bill Ackman.

Irvine Looks Both Ways on Great Park; Vexed About Vector

There’s plenty to look back upon at Great Park, as recent depositions in the City of Irvine’s forensic audit of operations reveal.

Louis Vuitton at Fashion Island? Alice’s Dance

Is that a Louis Vuitton store taking shape next to Neiman Marcus at Fashion Island?

Simon Scholars Find New Friend in Horatio Alger

National Organization Joins in $20M Commitment to College-Bound Kids in Need

Call them Simon Scholars with something extra.

No Summer Swoon for Wealthiest

Markets Cooperate as Entries Tally $54B

All the ingredients pointed to another good year for the richest residents of Orange County: an extraordinarily strong run in stocks, continued briskness in the commercial and residential real estate sectors, and some surprising resilience in the bond market.

OCMA Aims for $12.5M Per Acre; All Sorts of Sports

Members of our OC’s Wealthiest list—the centerpiece of a Special Report that starts on page 15— enjoyed a good turn in terms of their finances over the past 12 months, even with the sharp dip for the Dow Jones late last week.

Pyott on Points; Goodwill Gala; Reiff Steppes Up

The quick takeaway from last week’s Allergan action: Round 1 goes to David Pyott on points—and an acquisition would knock Valeant out cold

Tie Goes to Pyott?; Something Cool in South Coast Metro

The Insider isn’t ready to make a flat-out prediction but will say this much on the latest turn in the Allergan-Valeant saga: It looks as though David Pyott can play for a tie while his opponents have to win—and do it in regulation time.

Irvine’s Outsized Rep; SCR Goes to Santana; Augie Takes a Hike

Sheril Liu of ReMax Premier Realty in Irvine put a clear focus on one of the ways the city—with a population a bit under 250,000—punches above its weight.

More stories